Northwest Biotherapeutics (NWBO) Other Operating Expenses (2014 - 2026)

Northwest Biotherapeutics' (NWBO) quarterly Other Operating Expenses came in at $2.2 million in Q1 2026, down 86.16% quarter-over-quarter from $16.3 million in Q3 2020.

Northwest Biotherapeutics (NWBO) Other Operating Expenses (2014 - 2026) Analysis & Trends

Northwest Biotherapeutics' Other Operating Expenses history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.

  • On a quarterly basis, Other Operating Expenses changed N/A year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $2.2 million, a N/A change from a year earlier, with the FY2018 full-year figure at $3.3 million, changed N/A from the prior year.
  • Other Operating Expenses fell to $2.2 million in Q1 2026 per NWBO's latest filing, from $16.3 million in the prior quarter.
  • Across five years, Other Operating Expenses topped out at $2.2 million in Q1 2026 and bottomed at $2.2 million in Q1 2026.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Northwest Biotherapeutics 253,653.43 -1.53 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2026 2.25 Mn
Sep 30, 2020 16.26 Mn
Jun 30, 2020 1.92 Mn
Mar 31, 2020 3.46 Mn
Dec 31, 2019 -3.26 Mn
Sep 30, 2019 802,000.00
Jun 30, 2019 914,000.00
Mar 31, 2019 1.54 Mn
Dec 31, 2018 448,000.00
Sep 30, 2018 1.95 Mn
Jun 30, 2018 901,000.00
Mar 31, 2018 1.21 Mn
Dec 31, 2017 1.51 Mn
Sep 30, 2017 1.60 Mn
Jun 30, 2017 2.00 Mn
Mar 31, 2017 3.93 Mn
Dec 31, 2016 1.55 Mn
Sep 30, 2016 1.91 Mn
Jun 30, 2016 4.54 Mn
Mar 31, 2016 940,000.00